메뉴 건너뛰기




Volumn 11, Issue 6, 2011, Pages 648-660

The Evolution of Histamine H3 Antagonists/Inverse Agonists

Author keywords

ADHD; Alzheimer's disease; Gpcr; Histamine; Obesity; Schizophrenia; Sleep wake

Indexed keywords

4 AMINOBUTYRIC ACID; 5 (4 CYANOPHENYL) 2 [2 (2 METHYL 1 IMIDAZOLIDINYL)ETHYL]BENZOFURAN; 6 (3 CYCLOBUTYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPIN 7 YLOXY) N METHYLNICOTINAMIDE; A 331440; A 423579; A 688057; A 698418; ABT 834; ACETYLCHOLINE; BF 2649; CIPRALISANT; CIPROXIFAN; CLOBENPROPIT; DOPAMINE; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; GSK 1004723; GSK 239512; GSK 835726; GW 784568; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; JNJ 10181457; JNJ 17216498; JNJ 5207852; JNJ 6379490; JNJ 7737782; MK 0249; NORADRENALIN; PF 03654746; SEROTONIN; THIOPERAMIDE; UCL 1972; UCL 2190; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 79952914558     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026611109060648     Document Type: Article
Times cited : (30)

References (90)
  • 4
    • 35748932644 scopus 로고    scopus 로고
    • Recent advances in drug discovery of histamine H3 antagonist
    • Hudkins, R. L.; Raddatz, R. Recent advances in drug discovery of histamine H3 antagonist. Ann. Rep. Med. Chem., 2008, 42, 49-63.
    • (2008) Ann. Rep. Med. Chem , vol.42 , pp. 49-63
    • Hudkins, R.L.1    Raddatz, R.2
  • 6
    • 57349083232 scopus 로고    scopus 로고
    • Histamine H3 receptor antagonists go to the clinic
    • Sander, K.; Kottke, T.; Stark, H. Histamine H3 receptor antagonists go to the clinic. Biol. Pharm. Bull., 2008, 31, 2163-2181.
    • (2008) Biol. Pharm. Bull. , vol.31 , pp. 2163-2181
    • Sander, K.1    Kottke, T.2    Stark, H.3
  • 7
    • 77949353387 scopus 로고    scopus 로고
    • Histamine H3 antagonists for the treatment of cognitive deficits in CNS diseases
    • Raddatz, R.; Tao, M.; Hudkins, R. L. Histamine H3 antagonists for the treatment of cognitive deficits in CNS diseases. Curr. Top. Med. Chem., 2010, 10, 153-169.
    • (2010) Curr. Top. Med. Chem , vol.10 , pp. 153-169
    • Raddatz, R.1    Tao, M.2    Hudkins, R.L.3
  • 11
    • 0020587209 scopus 로고
    • Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
    • Arrang, J. M.; Garbarg, M.; Schwartz, J. C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature, 1983, 302, 832-837.
    • (1983) Nature , vol.302 , pp. 832-837
    • Arrang, J.M.1    Garbarg, M.2    Schwartz, J.C.3
  • 14
    • 0026612268 scopus 로고
    • Histamine H3: A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex
    • Schlicker, E.; Behling, A.; Lümmen, G.; Göthert, M. Histamine H3: A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn Schmiedebergs Arch. Pharmacol., 1992,345, 489-493.
    • (1992) Naunyn Schmiedebergs Arch. Pharmacol , vol.345 , pp. 489-493
    • Schlicker, E.1    Behling, A.2    Lümmen, G.3    Göthert, M.4
  • 15
    • 0028325424 scopus 로고
    • Modulation of neurotransmitter release via histamine H3 heteroreceptors
    • Schlicker, E.; Malinowska, B.; Kathmann, M.; Gothert, M. Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fund. Clin. Pharmacol., 1994, 8, 128-137.
    • (1994) Fund. Clin. Pharmacol , vol.8 , pp. 128-137
    • Schlicker, E.1    Malinowska, B.2    Kathmann, M.3    Gothert, M.4
  • 16
    • 0034047202 scopus 로고    scopus 로고
    • Cloning of rat histamine H3 receptor reveals distinct species pharmacological profiles
    • Lovenberg, T. W.; Pyati, J.; Chang, H.; Wilson, S. J.; Erlander, M. G. Cloning of rat histamine H3 receptor reveals distinct species pharmacological profiles. J. Pharm. Exp. Ther., 2000, 293, 771-778.
    • (2000) J. Pharm. Exp. Ther , vol.293 , pp. 771-778
    • Lovenberg, T.W.1    Pyati, J.2    Chang, H.3    Wilson, S.J.4    Erlander, M.G.5
  • 18
    • 0036282457 scopus 로고    scopus 로고
    • Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor
    • Wellendorph, P.; Goodman, M. W.; Burstein, E. S.; Nash, N. R.; Brann, M. R.; Weiner, D. M. Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor. Neuropharmacology, 2002, 42, 929-940.
    • (2002) Neuropharmacology , vol.42 , pp. 929-940
    • Wellendorph, P.1    Goodman, M.W.2    Burstein, E.S.3    Nash, N.R.4    Brann, M.R.5    Weiner, D.M.6
  • 21
    • 57349094379 scopus 로고    scopus 로고
    • Design of potent GlyT1 inhibitors: In vitro and in vivo profiles
    • Bridges, T.M.; Williams, R.; Lindsley, C.W. Design of potent GlyT1 inhibitors: in vitro and in vivo profiles. Curr. Opin. Mol. Ther., 2008, 10, 591-604.
    • (2008) Curr. Opin. Mol. Ther , vol.10 , pp. 591-604
    • Bridges, T.M.1    Williams, R.2    Lindsley, C.W.3
  • 23
    • 0346100541 scopus 로고    scopus 로고
    • An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration
    • Liu, H.; Kerdesky, F. A.; Black, L. A.; Fitzgerald, M.; Henry, R.; Esbenshade, T. A.; Hancock, A. A.; Bennani, Y. L. An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration. J. Org. Chem., 2004, 69, 192-194.
    • (2004) J. Org. Chem , vol.69 , pp. 192-194
    • Liu, H.1    Kerdesky, F.A.2    Black, L.A.3    Fitzgerald, M.4    Henry, R.5    Esbenshade, T.A.6    Hancock, A.A.7    Bennani, Y.L.8
  • 26
    • 0000217390 scopus 로고
    • Turbotoxins A and B, novel diiodotyramine derivatives from the Japanese gastropod Turbo marmorata
    • Xynas, R.; Capon, R. Turbotoxins A and B, novel diiodotyramine derivatives from the Japanese gastropod Turbo marmorata. Aust. J. Chem., 1989, 42, 1427-1433.
    • (1989) Aust. J. Chem , vol.42 , pp. 1427-1433
    • Xynas, R.1    Capon, R.2
  • 28
    • 33644834851 scopus 로고    scopus 로고
    • The challenge of drug discovery of a GPCR target: Analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists
    • Hancock, A. A. The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists. Biochem. Pharmacol., 2006, 71, 1103-1113.
    • (2006) Biochem. Pharmacol. , vol.71 , pp. 1103-1113
    • Hancock, A.A.1
  • 33
    • 70349083023 scopus 로고    scopus 로고
    • Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists
    • Hay, T.; Jones, R.; Beaumont, K.; Kemp, M. Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists. Drug Metab. Dispos., 2009, 37, 1864-1870.
    • (2009) Drug Metab. Dispos , vol.37 , pp. 1864-1870
    • Hay, T.1    Jones, R.2    Beaumont, K.3    Kemp, M.4
  • 38
    • 55549142497 scopus 로고    scopus 로고
    • Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists
    • Mizutani, T.; Nagase, T.; Ito, S.; Miyamoto, Y.; Tanaka, T.; Takenaga, N.; Tokita, S.; Sato, N. Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists. Bioorg. Med. Chem. Lett., 2008, 18, 6041-6045.
    • (2008) Bioorg. Med. Chem. Lett , vol.18 , pp. 6041-6045
    • Mizutani, T.1    Nagase, T.2    Ito, S.3    Miyamoto, Y.4    Tanaka, T.5    Takenaga, N.6    Tokita, S.7    Sato, N.8
  • 39
    • 67649983981 scopus 로고    scopus 로고
    • Development of a selective and potent radioactive ligand for histamine H3 receptors: A compound potentially useful for receptor occupancy studies
    • Mitobe, Y.; Ito, S.; Mizutani, T.; Nagase, T.; Sato, N.; Tokita, S. Development of a selective and potent radioactive ligand for histamine H3 receptors: A compound potentially useful for receptor occupancy studies. Bioorg. Med. Chem. Lett., 2009, 19, 4075-4078.
    • (2009) Bioorg. Med. Chem. Lett , vol.19 , pp. 4075-4078
    • Mitobe, Y.1    Ito, S.2    Mizutani, T.3    Nagase, T.4    Sato, N.5    Tokita, S.6
  • 41
    • 51349160447 scopus 로고    scopus 로고
    • Synthesis and evaluation of a spiroisobenzofuranone class of histamine H3 receptor inverse agonists
    • Jitsuoka, M.; Tsukahara, D.; Ito, S.; Tanaka, T.; Takenaga, N.; Tokita, S.; Sato, N. Synthesis and evaluation of a spiroisobenzofuranone class of histamine H3 receptor inverse agonists. Bioorg. Med. Chem. Lett., 2008, 18, 5101-5106.
    • (2008) Bioorg. Med. Chem. Lett , vol.18 , pp. 5101-5106
    • Jitsuoka, M.1    Tsukahara, D.2    Ito, S.3    Tanaka, T.4    Takenaga, N.5    Tokita, S.6    Sato, N.7
  • 43
    • 34250179519 scopus 로고    scopus 로고
    • A new class of histamine H3 receptor antagonists derived from ligand based design. Bioorg. Med
    • Roche, O.; Rodríguez, R. M. A new class of histamine H3 receptor antagonists derived from ligand based design. Bioorg. Med. Chem. Lett., 2007, 17, 3670-3675.
    • (2007) Chem. Lett , vol.17 , pp. 3670-3675
    • Roche, O.1    Rodríguez, R.M.2
  • 44
    • 47749128056 scopus 로고    scopus 로고
    • Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists
    • Roche, O.; Nettekoven, M.; Vifian, W.; Sarmiento, R. M. Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists. Bioorg. Med. Chem. Lett., 2008, 18, 4377-4379.
    • (2008) Bioorg. Med. Chem. Lett , vol.18 , pp. 4377-4379
    • Roche, O.1    Nettekoven, M.2    Vifian, W.3    Sarmiento, R.M.4
  • 45
    • 67649968886 scopus 로고    scopus 로고
    • Selective naphthalene H3 receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs
    • Rodríguez Sarmiento, R. M.; Nettekoven, M. H.; Taylor, S.; Plancher, J. M.; Richter, H.; Roche, O. Selective naphthalene H3 receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs. Bioorg. Med. Chem. Lett., 2009,19, 4495-4500
    • (2009) Bioorg. Med. Chem. Lett , vol.19 , pp. 4495-4500
    • Rodríguez sarmiento, R.M.1    Nettekoven, M.H.2    Taylor, S.3    Plancher, J.M.4    Richter, H.5    Roche, O.6
  • 46
    • 52949143487 scopus 로고    scopus 로고
    • The hERG channel and risk of drug-acquired cardiac arrhythmia: An overview
    • Lagrutta, A. A.; Trepakova, E. S.; Salata, J. J. The hERG channel and risk of drug-acquired cardiac arrhythmia: an overview. Curr. Top. Med. Chem., 2008, 8, 1102-1112.
    • (2008) Curr. Top. Med. Chem , vol.8 , pp. 1102-1112
    • Lagrutta, A.A.1    Trepakova, E.S.2    Salata, J.J.3
  • 50
    • 0028222730 scopus 로고
    • Verongamine, a novel bromotyrosine-derived histamine H3-antagonist from the marine sponge Verongula gigantea
    • Mierzwa, R.; King, A.; Conover, M. A.; Tozzi, S.; Puar, M. S.; Patel, M.; Coval, S. J.; Pomponi, S. A. Verongamine, a novel bromotyrosine-derived histamine H3-antagonist from the marine sponge Verongula gigantea. J. Nat. Prod., 1994, 57, 175-177.
    • (1994) J. Nat. Prod , vol.57 , pp. 175-177
    • Mierzwa, R.1    King, A.2    Conover, M.A.3    Tozzi, S.4    Puar, M.S.5    Patel, M.6    Coval, S.J.7    Pomponi, S.A.8
  • 52
    • 68549132508 scopus 로고    scopus 로고
    • Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-Alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships
    • Zhao, C.; Sun, M.; Bennani, Y. L.; Miller, T. R.; Witte, D. G.; Esbenshade, T. A.; Wetter, J.; Marsh, K. C.; Hancock, A. A.; Brioni, J. D.; Cowart, M. D. Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-Alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships. J. Med. Chem., 2009, 52(15), 4640-4649.
    • (2009) J. Med. Chem , vol.52 , Issue.15 , pp. 4640-4649
    • Zhao, C.1    Sun, M.2    Bennani, Y.L.3    Miller, T.R.4    Witte, D.G.5    Esbenshade, T.A.6    Wetter, J.7    Marsh, K.C.8    Hancock, A.A.9    Brioni, J.D.10    Cowart, M.D.11
  • 56
    • 40949124014 scopus 로고    scopus 로고
    • PF1270A, B and C, novel histamine H3 receptor ligands produced by Penicillium waksmanii PF1270
    • Kushida, N.; Watanabe, N.; Okuda, T.; Yokoyama, F.; Gyobu, Y.; Yaguchi, T.; PF1270A, B and C, novel histamine H3 receptor ligands produced by Penicillium waksmanii PF1270. J. Antibiot.,2007, 60, 667-673.
    • (2007) J. Antibiot , vol.60 , pp. 667-673
    • Kushida, N.1    Watanabe, N.2    Okuda, T.3    Yokoyama, F.4    Gyobu, Y.5    Yaguchi, T.6
  • 57
    • 56049125024 scopus 로고    scopus 로고
    • Total synthesis and biological evaluation of the marine bromopyrrole alkaloid dispyrin: Elucidation of discrete molecular targets with therapeutic potential
    • Kennedy, J. P.; Brogan, J. T.; Lindsley, C. W. Total synthesis and biological evaluation of the marine bromopyrrole alkaloid dispyrin: elucidation of discrete molecular targets with therapeutic potential. J. Nat. Prod., 2008, 71, 1783-1788.
    • (2008) J. Nat. Prod , vol.71 , pp. 1783-1788
    • Kennedy, J.P.1    Brogan, J.T.2    Lindsley, C.W.3
  • 58
    • 34249005543 scopus 로고    scopus 로고
    • Bromopyrrole carboxamide biosynthetic products from the Caribbean sponge Agelas dispar
    • Piña, I. C.; White, K. N.; Cabrera, G.; Rivero, E.; Crews, P. Bromopyrrole carboxamide biosynthetic products from the Caribbean sponge Agelas dispar. J. Nat. Prod., 2007, 70, 613-617.
    • (2007) J. Nat. Prod , vol.70 , pp. 613-617
    • Piña, I.C.1    White, K.N.2    Cabrera, G.3    Rivero, E.4    Crews, P.5
  • 59
    • 65749108134 scopus 로고    scopus 로고
    • A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin
    • Kennedy, J. P.; Conn, P. J.; Lindsley, C. W. A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin Bioorg. Med. Chem. Lett., 2009, 19, 3204-3208.
    • (2009) Bioorg. Med. Chem. Lett , vol.19 , pp. 3204-3208
    • Kennedy, J.P.1    Conn, P.J.2    Lindsley, C.W.3
  • 60
    • 62749126730 scopus 로고    scopus 로고
    • Rapid, general access to chiral flouroamines and, -difluoroamines via organocatalysis
    • Fadeyi, O.; Lindsley, C.W. Rapid, general access to chiral flouroamines and, -difluoroamines via organocatalysis. Org. Lett., 2009, 11, 943-946.
    • (2009) Org. Lett , vol.11 , pp. 943-946
    • Fadeyi, O.1    Lindsley, C.W.2
  • 72
    • 37149019944 scopus 로고    scopus 로고
    • A practical synthesis of enantiopure 7-alkoxy-4-aryltetrahydroisoquinoline, a dual serotonin reuptake inhibitor/ histamine H3 antagonist
    • Deng, X.; Liang, J. T.; Liu, J.; McAllister, H.; Schubert, C.; Mani, N. S. A practical synthesis of enantiopure 7-alkoxy-4-aryltetrahydroisoquinoline, a dual serotonin reuptake inhibitor/ histamine H3 antagonist. Org. Process Res. Dev., 2007, 11, 1043-1050.
    • (2007) Org. Process Res. Dev , vol.11 , pp. 1043-1050
    • Deng, X.1    Liang, J.T.2    Liu, J.3    McAllister, H.4    Schubert, C.5    Mani, N.S.6
  • 73
    • 57849138847 scopus 로고    scopus 로고
    • Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics
    • von Coburg, Y.; Kottke, T.; Weizel, L.; Ligneau, X.; Stark, H. Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics. Bioorg. Med. Chem. Lett., 2009, 19, 538-542.
    • (2009) Bioorg. Med. Chem. Lett , vol.19 , pp. 538-542
    • von Coburg, Y.1    Kottke, T.2    Weizel, L.3    Ligneau, X.4    Stark, H.5
  • 76
    • 79952932938 scopus 로고    scopus 로고
    • Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders
    • US6,906,081
    • Hey, J. A.; Aslanian, R. G. Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders. Schering Plough Corporation. US6,906,081. 2005.
    • (2005) Schering Plough Corporation
    • Hey, J.A.1    Aslanian, R.G.2
  • 77
    • 33645361406 scopus 로고    scopus 로고
    • Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents
    • Petroianu, G.; Arafat, K.; Sasse, B. C.; Stark, H. Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents. Pharmazie, 2006, 61, 179-182.
    • (2006) Pharmazie , vol.61 , pp. 179-182
    • Petroianu, G.1    Arafat, K.2    Sasse, B.C.3    Stark, H.4
  • 78
    • 0037186501 scopus 로고    scopus 로고
    • Development of a new class of nonimidazole histamine H3 receptor ligands with combined inhibitory histamine N-methyltransferase activity
    • Apelt, J.; Ligneau, X.; Pertz, H. H.; Arrang, J.-M.; Ganellin, C. R.; Schwartz, J.-C.; Schunack, W.; Stark, H. Development of a new class of nonimidazole histamine H3 receptor ligands with combined inhibitory histamine N-methyltransferase activity. J. Med. Chem., 2002, 45, 1128-1141.
    • (2002) J. Med. Chem , vol.45 , pp. 1128-1141
    • Apelt, J.1    Ligneau, X.2    Pertz, H.H.3    Arrang, J.-M.4    Ganellin, C.R.5    Schwartz, J.-C.6    Schunack, W.7    Stark, H.8
  • 81
    • 79952961185 scopus 로고    scopus 로고
    • Single and repeat dose first time in human study for an intranasal H1/H3 dual antagonist in healthy male subjects, Web Site, June 30
    • Single and repeat dose first time in human study for an intranasal H1/H3 dual antagonist in healthy male subjects. NCT00694993. ClinicalTrials.gov, Web Site 2008, June 30.
    • (2008) NCT00694993
  • 82
    • 79952943535 scopus 로고    scopus 로고
    • Prous Database
    • Prous Database, GSK-1004723D. Drug Data Rep., 2007, 29, 1000.
    • (2007) GSK-1004723D. Drug Data Rep , vol.29 , pp. 1000
  • 89
    • 44249085163 scopus 로고    scopus 로고
    • Correlation between ex vivo receptor occupancy and wakepromoting activity of selective H3 receptor antagonists
    • Le, S.; Gruner, J. A.; Mathiasen, J. R.; Marino, M. J.; Schaffhauser, H. Correlation between ex vivo receptor occupancy and wakepromoting activity of selective H3 receptor antagonists. J. Pharmacol. Exp. Ther., 2008, 325, 902-909.
    • (2008) J. Pharmacol. Exp. Ther , vol.325 , pp. 902-909
    • Le, S.1    Gruner, J.A.2    Mathiasen, J.R.3    Marino, M.J.4    Schaffhauser, H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.